Sitamaquine sensitivity in Leishmania species is not mediated by drug accumulation in acidocalcisomes.
about
Antimony-resistant clinical isolates of Leishmania donovani are susceptible to paromomycin and sitamaquineStructures, targets and recent approaches in anti-leishmanial drug discovery and development.Design and synthesis of novel antileishmanial compounds.Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis.The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei.Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistanceThe 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase.4-amino bis-pyridinium derivatives as novel antileishmanial agents.Peptidomimetic and organometallic derivatives of primaquine active against Leishmania infantumIncreased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania majorTafenoquine, an antiplasmodial 8-aminoquinoline, targets leishmania respiratory complex III and induces apoptosisSitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.Gene expression modulation and the molecular mechanisms involved in Nelfinavir resistance in Leishmania donovani axenic amastigotes.
P2860
Q35005213-12610F3A-0066-4327-9852-13119A12226AQ35012968-C34F4830-BD7E-4323-B177-7D2DF935558FQ35061244-1DE75457-3183-460B-B7CE-940C837C0779Q35666558-ACD6337C-A3E4-47D9-8767-95D1A32420F9Q36076081-CCAC8BC1-54B5-44B1-ABB8-632859340D81Q36899150-BE4A76D2-4F4C-4F2A-B9F6-893E7E4B57C6Q38283327-FB6F784E-DE53-4CA7-96A2-9A984D50707CQ38998325-6AC270C7-2191-4239-A2D0-CB278CBDDC85Q41569481-268729D1-F08C-43D9-B1F8-EE356609CAFDQ41984797-5C96EF40-9EA8-49CA-9C6A-2FD0A57BB35AQ42363610-6976B426-BC25-43F6-A8B6-D132D2A4F8CAQ42849844-D1D06F4C-CB93-47E5-A2B8-21AC544C04A3Q45302847-497F9FD2-9F87-42D9-B0D8-710DA8F727D4
P2860
Sitamaquine sensitivity in Leishmania species is not mediated by drug accumulation in acidocalcisomes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Sitamaquine sensitivity in Lei ...... cumulation in acidocalcisomes.
@en
Sitamaquine sensitivity in Lei ...... cumulation in acidocalcisomes.
@nl
type
label
Sitamaquine sensitivity in Lei ...... cumulation in acidocalcisomes.
@en
Sitamaquine sensitivity in Lei ...... cumulation in acidocalcisomes.
@nl
prefLabel
Sitamaquine sensitivity in Lei ...... cumulation in acidocalcisomes.
@en
Sitamaquine sensitivity in Lei ...... cumulation in acidocalcisomes.
@nl
P2860
P50
P356
P1476
Sitamaquine sensitivity in Lei ...... ccumulation in acidocalcisomes
@en
P2093
Carmen López-Martín
Luis Carvalho
P2860
P304
P356
10.1128/AAC.00964-08
P407
P577
2008-09-15T00:00:00Z